Dale H Conaway's Net Worth
-$408 Thousand
Who is Dale H Conaway?
Dale H Conaway does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Boston Therapeutics, Inc., BIOXYTRAN, INC, and PRO PHARMACEUTICALS INC.
SEC CIK
Dale H Conaway's CIK is 0001261770
Past Insider Trading and Trends
2007 was Dale H Conaway's most active year for acquiring shares with 9 total transactions. Dale H Conaway's most active month to acquire stocks was the month of January. 2020 was Dale H Conaway's most active year for disposing of shares, totalling 1 transactions. Dale H Conaway's most active month to dispose stocks was the month of October. 2024 saw Dale H Conaway paying a total of $409,502.84 for 1,733,452 shares, this is the most they've acquired in one year. In 2020 Dale H Conaway cashed out on 22,000 shares for a total of $132.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Boston Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +238.10% | 5K |
$0.12 | $600.00 | 7.1K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 8 - Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOXYTRAN, INC (BIXT) Snapshot price: $0.08165
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.73% | 20.62K |
$0.46 | $9,484.74 | 232.64K |
Oct 25
| |||
Form 4
| +149.13% | 1.4M |
$0.50 | $369,069.90 | 212.02K |
Aug 16 - Aug 19
| |||
Form 4
| +8.13% | 70.42K |
$0.14 | $10,000.07 | 936.12K |
Apr 19
| |||
Form 4
| +45.36% | 266.95K |
$0.11 | $30,432.87 | 855.48K |
Mar 27
| |||
Form 4
| +15.22% | 77.72K |
$0.19 | $15,000.15 | 588.52K |
Oct 31
| |||
Form 4
| +8.50% | 40K |
$0.15 | $6,000.00 | 510.8K |
Aug 4
| |||
Form 4
| +6.81% | 30K |
$0.45 | $13,440.00 | 470.8K |
Apr 18
| |||
Form 4
| +13.48% | 50K |
$0.23 | $11,500.00 | 420.8K |
Aug 4
| |||
Form 4
| +42.18% | 110K |
$0.05 | $5,180.00 | 370.8K |
Apr 2 - Nov 29
| |||
Form 4
| +690.30% | 227.8K |
$0.24 | $54,672.00 | 260.8K |
Jan 15
| |||
Form 4
| -40.00% | -22.00K |
$0.01 | -$132.00 | 33K |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PRO PHARMACEUTICALS INC (GALT) Snapshot price: $2.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 4
| +1.79% | 400 |
$0.75 | $300.00 | 22.81K |
Mar 29
| |||
Form 4
| +0.29% | 60 |
$1.20 | $72.00 | 20.41K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +9.80% | 2K |
$1.08 | $2,160.00 | 22.41K |
Mar 5
| |||
Form 4
| +0.29% | 60 |
$1.20 | $72.00 | 20.41K |
Feb 15
| |||
Form 4
| +58.38% | 7.5K |
$0.36 | $2,700.00 | 20.35K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
| No matching records found | |||||||||